Jul 30, 2024, 02:16
Myriam Chalabi: Abstract titles for ESMO24 are now online!
Myriam Chalabi shared on X:
”Abstract titles for ESMO24 now online!
Full NICHE-3 cohort (59 patients with dMMR colon cancer treated with neoadjuvant nivolumab/relatlimab) will be presented in proferred paper session + more neoadjuvant IO from Imhotep, and wonderful Jenny Seligmann as discussant. Stay tuned for more exciting news!”
Source: Myriam Chalabi/X
Myriam Chalabi is a Gastrointestinal Oncologist and clinician scientist at the Netherlands Cancer Institute in Amsterdam. In 2022 she was named one of the 11 early career researchers to watch by Nature Medicine. In 2023 she was awarded the ESMO José Baselga Fellowship for Clinician Scientists.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28